BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18259750)

  • 1. Interactions of host IL-6 and IFN-gamma and cancer-derived TGF-beta1 on MHC molecule expression during tumor spontaneous regression.
    Hsiao YW; Liao KW; Chung TF; Liu CH; Hsu CD; Chu RM
    Cancer Immunol Immunother; 2008 Jul; 57(7):1091-104. PubMed ID: 18259750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-beta 1 and restores the lymphokine-activated killing activity.
    Hsiao YW; Liao KW; Hung SW; Chu RM
    J Immunol; 2004 Feb; 172(3):1508-14. PubMed ID: 14734728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles.
    Chou PC; Chuang TF; Jan TR; Gion HC; Huang YC; Lei HJ; Chen WY; Chu RM
    Vet Immunol Immunopathol; 2009 Jul; 130(1-2):25-34. PubMed ID: 19200609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells.
    Hsiao YW; Liao KW; Hung SW; Chu RM
    Vet Immunol Immunopathol; 2002 Aug; 87(1-2):19-27. PubMed ID: 12052339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of the local inflammatory infiltrate in spontaneous canine transmissible venereal tumour at different stages of growth.
    Pérez J; Day MJ; Mozos E
    Vet Immunol Immunopathol; 1998 Jul; 64(2):133-47. PubMed ID: 9661263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells.
    Banu N; Meyers CM
    Kidney Int; 1999 Sep; 56(3):985-94. PubMed ID: 10469366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the tumour microenvironment alter tumorigenesis and clinical response in transmissible venereal tumour in dogs?
    Ballestero Fêo H; Montoya Flórez L; Yamatogi RS; Prado Duzanski A; Araújo JP; Oliveira RA; Rocha NS
    Vet Comp Oncol; 2018 Sep; 16(3):370-378. PubMed ID: 29508538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta1 and IFN-gamma cross-regulate antigen presentation to CD4 T cells by macrophages.
    Delvig AA; Lee JJ; Chrzanowska-Lightowlers ZM; Robinson JH
    J Leukoc Biol; 2002 Jul; 72(1):163-6. PubMed ID: 12101276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
    Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
    Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of inducible class II MHC, costimulatory molecules, and cytokine expression in TGF-beta1 knockout renal epithelial cells: effect of exogenous TGF-beta1.
    Banu N; Mozes MM; Kopp JB; Ziyadeh FN; Meyers CM
    Exp Nephrol; 2002; 10(5-6):320-31. PubMed ID: 12381916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules.
    Darley R; Morris A; Passas J; Bateman W
    Cancer Immunol Immunother; 1993 Jul; 37(2):112-8. PubMed ID: 8100485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
    Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
    Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor.
    Liu CC; Wang YS; Lin CY; Chuang TF; Liao KW; Chi KH; Chen MF; Chiang HC; Chu RM
    Cancer Immunol Immunother; 2008 Apr; 57(4):479-91. PubMed ID: 17710396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous canine immunotherapy: short-time generated dendritic cells loaded with canine transmissible venereal tumor-whole lysate.
    Franco-Molina MA; Ramos-Zayas Y; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
    Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):437-443. PubMed ID: 30507311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for the treatment of canine transmissible venereal tumor based in dendritic cells pulsed with tumoral exosomes.
    Ramos-Zayas Y; Franco-Molina MA; Hernádez-Granados AJ; Zárate-Triviño DG; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Ramírez-Romero R; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):48-54. PubMed ID: 30334465
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumour cell vaccines that secrete interleukin-2 (IL-2) and interferon gamma (IFN gamma) are recognised by T cells while resisting destruction by natural killer (NK) cells.
    Zier KS; Gansbacher B
    Eur J Cancer; 1996 Jul; 32A(8):1408-12. PubMed ID: 8869107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of DF3, in association with ICAM-1 and MHC class II by IFN-gamma in short-term human mammary carcinoma cell cultures.
    Sgagias MK; Nieroda C; Yannelli JR; Cowan KH; Danforth DN
    Cancer Biother Radiopharm; 1996 Jun; 11(3):177-85. PubMed ID: 10851535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine transmissible venereal tumor cell depletion of B lymphocytes: molecule(s) specifically toxic for B cells.
    Liao KW; Hung SW; Hsiao YW; Bennett M; Chu RM
    Vet Immunol Immunopathol; 2003 May; 92(3-4):149-62. PubMed ID: 12730015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10.
    O'Keefe GM; Nguyen VT; Benveniste EN
    Eur J Immunol; 1999 Apr; 29(4):1275-85. PubMed ID: 10229095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.